Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1951 AL 1965

Spaceflight-relevant microgravity triggers a sublethal Parkinson's-like dopaminergic decline in human neurons and organoids

Ali N, Arif S, Mortimer MF, Brandner M, Baldridge J, Paiva RF, Sane MS, Pu S, Woodbury L, Uzer G, Jorcyk C, Hampikian G, Laskar M, Oxford J.

bioRxiv [Preprint]. 2026 Jul 15:2026.07.09.737494. doi: 10.64898/2026.07.09.737494.

α-Synuclein pathology differentially alters T-type calcium currents in vulnerable and resilient substantia nigra dopaminergic subpopulations

Beaver ML, Bommareddy P, McLean NZ, Lewitus VJ, Maguire-Zeiss K, Evans RC.

bioRxiv [Preprint]. 2026 Jul 14:2026.07.10.737840. doi: 10.64898/2026.07.10.737840.

A novel rat model of body first subtype of Parkinson's disease

Peshattiwar V, Swain C, Pokharel D, Le K, Kennedy I, Venkiteswaran K, Subramanian T.

bioRxiv [Preprint]. 2026 Jul 19:2026.07.13.738258. doi: 10.64898/2026.07.13.738258.

The GRACE Cycle: A General Large-Language-Model Framework for Phenotype Discovery with Unknown Cluster Number

Wang J, Galis Z, Zhang T, Luo Y, Sra A, Niu X, Shen J, Xie Q, Weiss JC.

Res Sq [Preprint]. 2026 Jul 14:rs.3.rs-10048424. doi: 10.21203/rs.3.rs-10048424/v1.

Environmental determinants of Parkinson's disease and attributable burden in Latin America

Teixeira-Dos-Santos D, Chaparro-Solano HM, Duarte-Zambrano JF, Leal T, Inca-Martinez M, Waldo E, Noyce A, Adamec DS, Gatto EM, Santos-Lobato BL, Duarte JDS, Cardoso FEC, Letro GH, Arboleda G, Orozco J, Ospina BM, Medina-Cordero P, Chana-Cuevas P, Pizarro-Correa X, Salles P, Aguillon D, Pineda D, Martínez SLP, Ascencio T, Müller MV, Merello M, Wainberg FN, Braga-Neto P, Rangel D, Tela MS, Álvarez-Herrera E, Rodríguez-Violante M, Cervantes-Arriaga A, Martinez-Ramirez D, Schuh A, Rieder C, Cornejo-Olivas M, Armas C, Rios-Pinto J, Medina-Colque A, Mejia-Rojas K, Viñuela A, Rosso AL, Kauffman M, Tumas V, Vilela G, Borges V, Avila C, Olguín P, Colombo A, Nuñez JC, Jorquera S, Fernandez-Toledo E, Lázaro-Figueroa A, Esquivias-Farías JM, Estrada-Bellmann I, Reyes-Pérez P, Medina-Rivera A, Alcauter S, Muñoz-Quezada MT, Mata I.

Res Sq [Preprint]. 2026 Jul 14:rs.3.rs-10221836. doi: 10.21203/rs.3.rs-10221836/v1.

Transcranial low-intensity pulsed ultrasound in neurological disorders: mechanisms, therapeutic applications, and translational challenges

Cai H, Wang Y, Che S, Hou Z.

Front Neurol. 2026 Jul 14;17:1850924. doi: 10.3389/fneur.2026.1850924. eCollection 2026.

Perfusion as a biomarker of brain dysfunction in dementia (AD, DLB, FTD/PPA, PDD): comparison of CT, MRI (ASL/DSC/DCE), SPECT, and PET with interpretive pitfalls - a narrative review

Sklinda K, Bocianski J, Budlewski T, Kobylecka M, Dorobek M, Gorecki A, Mruk B, Błaszczak M, Walecki J.

Acta Neurol Belg. 2026 Jul 29. doi: 10.1007/s13760-026-03117-6. Online ahead of print.

Intranasal drug delivery to the brain for neurodegenerative diseases: Current efforts and challenges in delivery platforms and modeling

Bang KY, Walenga R, Chopski S, Luke MC, Blinova K, Zhao L, Guo S.

Adv Drug Deliv Rev. 2026 Jul 29;238:115938. doi: 10.1016/j.addr.2026.115938. Online ahead of print.

Amyloid Co-Pathology and Clinical Heterogeneity of Parkinson's Disease

Postuma RB.

Mov Disord. 2026 Jul 29. doi: 10.1002/mds.70459. Online ahead of print.

Epigenetic Mechanisms Underlying Cognitive Dysfunction in Parkinson's Disease: Current Evidence and Future Prospects

Hasani F, Kherad ME, Sarasyabi MS, Jazi K, Ashkbari A, Ahmadi P, Heidarpour H, Masrour M, Khamaki S, Rahmati R, Surguchov A.

Brain Behav. 2026 Aug;16(8):e71602. doi: 10.1002/brb3.71602.

AMPLITUDE PERFORMANCE SUBTYPES IN PARKINSON'S DISEASE

Mefferd AS, Tjaden K, Dietrich MS, Brown AE.

medRxiv [Preprint]. 2026 Jul 13:2026.07.08.26357552. doi: 10.64898/2026.07.08.26357552.

Implementation of a standardized Video-based Asynchronous Neurological Examination (VANE) in a multi-center observational study of Alzheimer's disease (AD) and AD related dementias

Noble JM, Nadkarni NK, Martinez D, Temprosa M, Bowers A, Carmichael O, Doherty L, Febres GJ, Sanchez D, Goldberg TE, Sherif H, Vallabh S, Luchsinger JA.

medRxiv [Preprint]. 2026 Aug 6:2026.07.15.26357456. doi: 10.64898/2026.07.15.26357456.

Characterizing the impact of plasma protein levels on human brain structure and disorders leveraging integrative multi-omics analysis

Ayubcha C, Dennis E, Bhattacharyya U, John J, Lam M, Lencz T, Ge T, Chen CY.

medRxiv [Preprint]. 2026 Jul 15:2026.07.13.26358006. doi: 10.64898/2026.07.13.26358006.

The dual pathological roles and targeted therapy of PGE(2): from receptor signaling networks to disease microenvironment modulation

Yang M, Gao Z, Zhao Z, Niu X, Xue F, Zhang J, Sun H, Shen Y, Liu G.

Front Pharmacol. 2026 Jul 15;17:1810417. doi: 10.3389/fphar.2026.1810417. eCollection 2026.

Effects of wearable devices on gait, balance, and motor function in people with Parkinson's disease: a systematic review and meta-analysis

Zhong Q, Liu D, Xu Y, Xiao G.

Front Public Health. 2026 Jul 15;14:1846005. doi: 10.3389/fpubh.2026.1846005. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias